Markets:

Overview

News

Currencies

International

Treasuries

PTC Therapeutics, Inc. - Common Stock (NQ:PTCT)

75.76 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 3, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about PTC Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

PTC Therapeutics Stock Sees IBD RS Rating Climb To 72 ↗

May 01, 2024

PTC Therapeutics stock saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, rising from 61 to 72.

Via Investor's Business Daily

PTCT Stock Earnings: PTC Therapeutics Beats EPS, Beats Revenue for Q1 2024 ↗

April 25, 2024

PTCT stock results show that PTC Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday ↗

March 01, 2024

U.S. stocks were higher, with the Nasdaq Composite gaining around 0.5% on Friday.

Via Benzinga

Topics Stocks

Recap: PTC Therapeutics Q4 Earnings ↗

February 29, 2024

Via Benzinga

Earnings Scheduled For February 29, 2024 ↗

February 29, 2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.

Via Benzinga

Earnings Preview: PTC Therapeutics ↗

February 28, 2024

Via Benzinga

Analyst Expectations for PTC Therapeutics's Future ↗

November 20, 2023

Via Benzinga

Earnings Preview: PTC Therapeutics ↗

October 25, 2023

Via Benzinga

1 of Sarepta Therapeutics' Competitors Just Got Hammered. Will It Help the Stock? ↗

February 11, 2024

Bad news for one player does not always equal good news for another.

Via The Motley Fool

PTC Therapeutics Flashes A Bearish Sign After European Officials Reject DMD Drug ↗

January 26, 2024

European regulators will likely force PTC Therapeutics to pull its drug, Translarna, from the market.

Via Investor's Business Daily

PTC Therapeutics To Withdraw Its Conditionally Approved Rare Muscle Disorder Disorder Drug In Europe ↗

January 26, 2024

CHMP issues negative opinion on PTC Therapeutics' Translarna for Duchenne Muscular Dystrophy. CEO expresses disappointment.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 26, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

January 25, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 27, 2023

Via Benzinga

Why Is Gene Therapy Player PTC Therapeutics Stock Plunging Today? ↗

October 27, 2023

In its Q3 earnings release, PTC Therapeutics Inc (NASDAQ: PTCT) reported a

Via Benzinga

ALGN Stock Alert: Align Technology Announces $250M Stock Buyback Program ↗

October 27, 2023

Align Technology stock is rising on Friday after the company announced plans to repurchase $250 million worth of ALGN shares.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 27, 2023

Via Benzinga

RBLX Stock Alert: Analysts Are Pounding the Table on Roblox ↗

October 27, 2023

Roblox stock is rising higher on Friday after analysts upgraded shares of RBLX and increased price targets for the gaming company.

Via InvestorPlace

Why Is PTC Therapeutics (PTCT) Stock Down 23% Today? ↗

October 27, 2023

PTC Therapeutics stock is falling on Friday as PTCT investors react to the company's lackluster earnings report for Q3 2023.

Via InvestorPlace

Amazon To Rally Around 55%? Here Are 10 Top Analyst Forecasts For Friday ↗

October 27, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

October 27, 2023

It's time to start off the final trading day this week with a breakdown of the biggest pre-market stock movers on Friday!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 26, 2023

Via Benzinga

Why PTC Therapeutics Soared 15% Higher Today ↗

October 19, 2023

The company scored a $1 billion upfront payment for expanding a commercial partnership.

Via The Motley Fool

Nasdaq Falls 100 Points; AT&T Posts Upbeat Earnings ↗

October 19, 2023

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling around 100 points on Thursday. The Dow traded down 0.43% to 33,520.17 while the NASDAQ fell 0.75% to 13,214.04. The...

Via Benzinga

Topics Stocks

Why Nokia Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

October 19, 2023

Gainers

Via Benzinga

AT&T, Union Pacific, Las Vegas Sands And Other Big Stocks Moving Higher On Thursday ↗

October 19, 2023

U.S. stocks traded slightly higher, with the Nasdaq Composite gaining around 30 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 19, 2023

Via Benzinga

NASDAQ:PTCT Shareholder Notice: Investigation over Possible Securities Laws Violations by PTC Therapeutics, Inc. ↗

October 10, 2023

San Diego, CA -- (SBWIRE) -- 10/10/2023 -- PTC Therapeutics, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.

Via SBWire

10 Health Care Stocks Whale Activity In Today's Session ↗

October 02, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023 ↗

October 06, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

PTC Therapeutics, Inc. - Common Stock (NQ:PTCT)

All News about PTC Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today